155 related articles for article (PubMed ID: 25095502)
21. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
22. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
Lisik W; Schoenberg L; Lasky RE; Kahan BD
Transplant Proc; 2007 Dec; 39(10):3086-92. PubMed ID: 18089328
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of high-intensity statin therapy in heart transplant patients receiving immunosuppression with tacrolimus.
Heeney SA; Tjugum SL; Corkish ME; Hollis IB
Clin Transplant; 2019 Jan; 33(1):e13454. PubMed ID: 30485535
[TBL] [Abstract][Full Text] [Related]
25. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
26. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
27. Statins as novel immunomodulators: from cell to potential clinical benefit.
Mach F
Thromb Haemost; 2003 Oct; 90(4):607-10. PubMed ID: 14515180
[TBL] [Abstract][Full Text] [Related]
28. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
[TBL] [Abstract][Full Text] [Related]
29. The University of California at Los Angeles heart transplantation experience.
Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A
Clin Transpl; 2005; ():173-85. PubMed ID: 17424734
[TBL] [Abstract][Full Text] [Related]
30. Evidence-based use of statins for primary prevention of cardiovascular disease.
Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
[TBL] [Abstract][Full Text] [Related]
31. The effect of statins on cardiac allograft survival.
Luo CM; Chou NK; Chi NH; Chen YS; Yu HY; Chang CH; Wang CH; Tsao CI; Wang SS
Transplant Proc; 2014 Apr; 46(3):920-4. PubMed ID: 24767381
[TBL] [Abstract][Full Text] [Related]
32. Cardiac allograft vasculopathy after heart transplantation: risk factors and management.
Valantine H
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S187-93. PubMed ID: 15093804
[TBL] [Abstract][Full Text] [Related]
33. Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.
Wenke K; Meiser B; Thiery J; Reichart B
Herz; 2005 Aug; 30(5):431-2. PubMed ID: 16132246
[TBL] [Abstract][Full Text] [Related]
34. Management of hyperlipidaemia associated with heart transplantation.
Wenke K
Drugs; 2004; 64(10):1053-68. PubMed ID: 15139786
[TBL] [Abstract][Full Text] [Related]
35. Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant recipients.
de Denus S; Al-Jazairi A; Loh E; Jessup M; Stanek EJ; Spinler SA
Ann Pharmacother; 2004; 38(7-8):1136-41. PubMed ID: 15150383
[TBL] [Abstract][Full Text] [Related]
36. Calcineurin inhibitors in heart transplantation.
Keogh A
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
[TBL] [Abstract][Full Text] [Related]
37. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of combined heart and kidney transplantation: a French multicenter study.
Vermes E; Grimbert P; Sebbag L; Barrou B; Pouteil-Noble C; Pavie A; Obadia JF; Loisance D; Lang P; Kirsch M
J Heart Lung Transplant; 2009 May; 28(5):440-5. PubMed ID: 19416771
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
[TBL] [Abstract][Full Text] [Related]
40. In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study.
Zakliczynski M; Boguslawska J; Wojniak E; Zakliczynska H; Ciesla D; Nozynski J; Szygula-Jurkiewicz B; Zeglen S; Zembala M
Transplant Proc; 2011 Oct; 43(8):3071-3. PubMed ID: 21996228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
